Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-31 @ 2:25 PM
Study NCT ID:
NCT04044560
Status:
TERMINATED
Last Update Posted:
2022-02-21
First Post:
2019-07-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant
Sponsor:
University of British Columbia
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-02
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-31
First Submit QC Date:
None
Study First Post Date:
2019-08-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-03
Last Update Post Date:
2022-02-21
Last Update Post Date Type:
ACTUAL